U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Stricture of intestine

MedGen UID:
473004
•Concept ID:
C0267465
•
Disease or Syndrome
Synonyms: Enterostenosis; Intestinal Stricture; Stenosis of intestine
SNOMED CT: Stenosis of intestine (23065003); Enterostenosis (23065003); Stricture of intestine (56226004)

Definition

Fibrosis of the wall of a segment of the intestine that leads to intestinal lumen narrowing. [from NCI]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVStricture of intestine

Professional guidelines

PubMed

AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
Hashash JG, Elkins J, Lewis JD, Binion DG
Gastroenterology 2024 Mar;166(3):521-532. Epub 2024 Jan 23 doi: 10.1053/j.gastro.2023.11.303. PMID: 38276922
Management of Crohn Disease: A Review.
Cushing K, Higgins PDR
JAMA 2021 Jan 5;325(1):69-80. doi: 10.1001/jama.2020.18936. PMID: 33399844Free PMC Article
Treatment Algorithms for Crohn's Disease.
Sulz MC, Burri E, Michetti P, Rogler G, Peyrin-Biroulet L, Seibold F; on behalf of the Swiss IBDnet, an official working group of the Swiss Society of Gastroenterology
Digestion 2020;101 Suppl 1:43-57. Epub 2020 Mar 13 doi: 10.1159/000506364. PMID: 32172251

Recent clinical studies

Etiology

Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and Safety.
Liu J, Sylwestrzak G, Ruggieri AP, DeVries A
J Manag Care Spec Pharm 2015 Jul;21(7):559-66. doi: 10.18553/jmcp.2015.21.7.559. PMID: 26108380Free PMC Article

Diagnosis

Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and Safety.
Liu J, Sylwestrzak G, Ruggieri AP, DeVries A
J Manag Care Spec Pharm 2015 Jul;21(7):559-66. doi: 10.18553/jmcp.2015.21.7.559. PMID: 26108380Free PMC Article

Therapy

Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and Safety.
Liu J, Sylwestrzak G, Ruggieri AP, DeVries A
J Manag Care Spec Pharm 2015 Jul;21(7):559-66. doi: 10.18553/jmcp.2015.21.7.559. PMID: 26108380Free PMC Article

Prognosis

Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and Safety.
Liu J, Sylwestrzak G, Ruggieri AP, DeVries A
J Manag Care Spec Pharm 2015 Jul;21(7):559-66. doi: 10.18553/jmcp.2015.21.7.559. PMID: 26108380Free PMC Article

Clinical prediction guides

Intravenous Versus Subcutaneous Anti-TNF-Alpha Agents for Crohn's Disease: A Comparison of Effectiveness and Safety.
Liu J, Sylwestrzak G, Ruggieri AP, DeVries A
J Manag Care Spec Pharm 2015 Jul;21(7):559-66. doi: 10.18553/jmcp.2015.21.7.559. PMID: 26108380Free PMC Article

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...